The American Society of Nephrology (ASN) has announced its new president – Michelle A. Josephson, MD, FASN – will be the next president of the society in place of Susan E. Quaggin, MD, FASN from next year.
Dr. Josephson is a highly experienced physician as well as an academic leader. His current work involves him serving as a professor of Medicine and Surgery at the University of Chicago, medical director of the University of Chicago Kidney and Pancreas Transplant Program, and program director of the Transplant Nephrology Fellowship.
Dr. Josephson is deeply committed to research, education, and care in the realm of kidney transplantation, with particular interests in living kidney donation, post-transplant bone disease, BK virus, and pregnancy in transplant recipients. Having authored more than 100 articles and 5 book chapters and having presented numerous invited lectures nationally and internationally, Dr. Josephson has helped to shape the field of nephrology—from clinical research to clinical care, to education for the next generation of nephrologists.
Dr. Josephson currently serves on the ASN Council as President-Elect. She has served as chair of the Transplant Advisory Group, the Policy and Advocacy Committee, and the ASN Early Program on Kidney Transplantation. She has also been a member of numerous ASN committees and groups, including the ASN COVID response team. Dr. Josephson chaired the American Society of Transplantation (AST) Cutting Edge of Transplantation 2020 and 2021 meetings, and the KDIGO Controversies Conference on the Failing Allograft. From 2007 to 2010 she served as a Councilor-at-Large on the AST Board of Directors. From 2005-2006 she was President of Women in Nephrology. She serves on the editorial board of CJASN and was an Associate Editor for Transplantation.
“It’s an exciting time to be ASN’s incoming president,” said Dr. Josephson. “I’m truly honored to be in this role as we continue to see numerous advances and increased awareness related to kidney health with ASN at the forefront.”